Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Antibacterianos/uso terapéutico,
Inhibidores de la Bomba de Protones/uso terapéutico,
Bismuto/uso terapéutico,
Algoritmos,
Técnica Delphi,
Quimioterapia Combinada,
Gastritis/complicaciones,
Infecciones por Helicobacter,
Helicobacter pylori,
Probióticos,
Inhibidores de la Bomba de Protones,
Recurrencia,
Terapia Recuperativa,
Neoplasias Gástricas,
Úlcera Gástrica,
Insuficiencia del Tratamiento,
Gastritis/tratamiento farmacológico,
Infecciones por Helicobacter/tratamiento farmacológico,
Helicobacter pylori/efectos de los fármacos
Nahid, P;
Dorman, SE;
Alipanah, N;
Barry, PM;
Brozek, JL;
Cattamanchi, A;
Chaisson, LH;
Chaisson, RE;
Daley, CL;
Grzemska, M;
Higashi, JM;
Ho, CS;
Ho, CS;
Hopewell, PC;
Keshavjee, SA;
Lienhardt, C;
Menzies, R;
Merrifield, C;
Narita, M;
O'Brien, R;
Peloquin, CA;
Raftery, A;
Saukkonen, J;
Schaaf, HS;
Sotgiu, G;
Starke, JR;
Migliori, GB;
Vernon, A.
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this guideline for the treatment of drug-susceptible tuberculosis, which is also endorsed by the European Respiratory Society and the US National Tube...
Fernández-Bañares, F;
Accarino, A;
Balboa, A;
Domènech, E;
Esteve, M;
Garcia-Planella, E;
Guardiola, J;
Molero, X;
Rodríguez-Luna, A;
Ruiz-Cerulla, A;
Santos, J;
Vaquero, E.
Chronic diarrhoea is a common presenting symptom in both primary care medicine and in specialized gastroenterology clinics. It is estimated that >5% of the population has chronic diarrhoea and nearly 40% of these patients are older than 60 years. Clinicians often need to select the best diagnostic approa...
Antidiarreicos/uso terapéutico,
Azúcares de la Dieta/efectos adversos,
Algoritmos,
Enfermedad Crónica,
Colitis,
Técnicas de Diagnóstico del Sistema Digestivo,
Diarrea,
Dieta,
Síndromes de Malabsorción/diagnóstico,
Manejo de la Enfermedad,
Insuficiencia Pancreática Exocrina,
Hipersensibilidad a los Alimentos,
Enfermedades Gastrointestinales,
Microbioma Gastrointestinal,
Motilidad Gastrointestinal,
Síndromes de Malabsorción,
Hipersensibilidad a los Alimentos/diagnóstico,
Diarrea/terapia,
Diarrea/diagnóstico,
Diarrea/clasificación
Ren, CL;
Esther CR, Jr;
Debley, JS;
Sockrider, M;
Yilmaz, O;
Amin, N;
Bazzy-Asaad, A;
Davis, SD;
Durand, M;
Ewig, JM;
Yuksel, H;
Lombardi, E;
Noah, TL;
Radford, P;
Ranganathan, S;
Teper, A;
Weinberger, M;
Brozek, J;
Wilson, KC.
"BACKGROUND:
Infantile wheezing is a common problem, but there are no guidelines for the evaluation of infants with recurrent or persistent wheezing that is not relieved or prevented by standard therapies.
METHODS:
An American Thoracic Society-sanctioned guideline development committee selected clinical...
Hingorani, A;
LaMuraglia, G. M;
Henke, P;
Meissner, M. H;
Loretz, L;
Zinszer, K. M;
Driver, V. R;
Frykberg, R;
Carman, T. L;
Marston, W;
Mills, J. L;
Murad, M. H.
Diabetes mellitus continues to grow in global prevalence and to consume an increasing amount of health care resources. One of the key areas of morbidity associated with diabetes is the diabetic foot. To improve the care of patients with diabetic foot and to provide an evidence-based multidisciplinary man...
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice Guideline for Hemodialysis Adequacy is intended to...
Bretonnière, C;
Leone, M;
Milési, C;
Allaouchiche, B;
Armand-Lefevre, L;
Baldesi, O;
Bouadma, L;
Decré, D;
Figueiredo, S;
Gauzit, R;
Guery, B;
Joram, N;
Jung, B;
Lasocki, S;
Lepape, A;
Lesage, F;
Pajot, O;
Philippart, F;
Souweine, B;
Tattevin, P;
Timsit, J. F;
Vialet, R;
Zahar, J. R;
Misset, B;
Bedos, J. P.
Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Société de Réanimat...
The use of probiotics has been suggested in the treatment of acute gastroenteritis (AGE) in addition to early rehydration and avoidance of dietary restrictions. This document provides recommendations for the use of probiotics for the treatment of AGE in previously healthy infants and children based on a ...
Tacconelli, E;
Cataldo, MA;
Dancer, SJ;
De, Angelis, G;
Falcone, M;
Frank, U;
Kahlmeter, G;
Pan, A;
Petrosillo, N;
Rodríguez-Baño, J;
Singh, N;
Venditti, M;
Yokoe, DS;
Cookson, B.
Healthcare-associated infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) are a leading cause of morbidity and mortality worldwide. These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions aimed ...
Antiinfecciosos Locales,
Clorhexidina,
Técnicas de Tipificación Bacteriana,
Infección Hospitalaria,
Brotes de Enfermedades/prevención & control,
Farmacorresistencia Bacteriana Múltiple,
Bacterias Gramnegativas/aislamiento & purificación,
Higiene de las Manos,
Conocimientos, Actitudes y Práctica en Salud,
Control de Infecciones,
Factores de Riesgo,
Infección Hospitalaria/prevención & control,
Infección Hospitalaria/transmisión,
Infecciones por Bacterias Gramnegativas/prevención & control,
Infecciones por Bacterias Gramnegativas/transmisión
Factor de Necrosis Tumoral alfa,
Mercaptopurina,
Azatioprina,
Metotrexato,
Enfermedad de Crohn,
Gastroenterología,
Mercaptopurina/uso terapéutico,
Metotrexato/uso terapéutico,
Inducción de Remisión,
Enfermedad de Crohn/tratamiento farmacológico,
Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
